Skip to main content
. 2022 Jan 4;13:100197. doi: 10.1016/j.mtbio.2021.100197

Fig. 4.

Fig. 4

(a) Schematic illustration of the synthesis of EA-Fe@BSA NPs for PT-enhanced CDT. In vivo MR images of the tumor and liver (b), and kidney (c) after intravenous injection of EA-Fe@BSA NPs. The corresponding MR signal intensities of the tumor (d), liver (e), and kidney (f) images. Reprinted with permission of Ref. [110]. Copyright 2020 IVYSPRING International Publisher.